DCM Shriram Fine Chemicals Issues Correction for Credit Rating Disclosure Filing
DCM Shriram Fine Chemicals Limited corrected a regulatory filing error regarding its credit rating disclosure. The company had received CARE A- stable rating for Rs. 30.00 crores long-term facilities and CARE A2+ for Rs. 17.20 crores short-term facilities, but incorrectly referenced SEBI takeover regulations instead of listing regulations in the original filing.

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals Limited has issued a correction letter to both BSE and National Stock Exchange regarding an error in its previous credit rating disclosure filed on April 08, 2026. The company acknowledged a typographical mistake in referencing SEBI regulations in its original filing.
Credit Rating Assignment
The company had initially announced the assignment of credit ratings by CARE Ratings Limited for its various bank facilities. CARE Ratings issued a press release dated April 07, 2026, assigning credit ratings for both long-term and short-term bank facilities.
| Facility/Instrument: | Amount (Rs. Crores) | Rating | Rating Action |
|---|---|---|---|
| Long-Term Bank Facilities: | 30.00 | CARE A- ; stable | Assigned |
| Short-term Bank Facilities: | 17.20 | CARE A2+ | Assigned |
Regulatory Correction
In the correction letter dated April 14, 2026, DCM Shriram Fine Chemicals acknowledged that it erroneously referenced "Regulation 30 read with Schedule III of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011" instead of the correct "Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015."
The correction letter was signed by Kokila Arora, Company Secretary & Compliance Officer (ACS 21670), and digitally submitted to both stock exchanges. The company expressed regret for the error and requested the exchanges to take the apology letter on record.
Company Information
DCM Shriram Fine Chemicals Limited is listed on BSE with Scrip Code 544703 and on National Stock Exchange with Scrip Code DSFCL. The company operates manufacturing facilities including Daurala Organics and Daurala Chemicals, located on Sardhana Road, Daurala, Meerut, Uttar Pradesh.
Will DCM Shriram Fine Chemicals seek to upgrade its CARE A- rating in the next 12-18 months as it expands its manufacturing capacity?
How might this credit rating assignment impact the company's borrowing costs and future capital expenditure plans?
Could this regulatory filing error trigger increased scrutiny from SEBI or affect the company's compliance track record?






























